Home Based Phototherapy for Neonatal Jaundice
Using Community Health Workers and In-home LED Phototherapy to Dramatically Reduce Brain Damage From Neonatal Jaundice in Low to Middle Income Countries: A Feasibility Trial
1 other identifier
interventional
500
1 country
1
Brief Summary
The main purpose of the study is to deliver community health worker based prevention, early screening and management of neonatal Jaundice using battery powered LED phototherapy device at the household level.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2019
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 23, 2019
CompletedFirst Posted
Study publicly available on registry
May 1, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedMarch 31, 2022
March 1, 2022
3.6 years
April 23, 2019
March 29, 2022
Conditions
Outcome Measures
Primary Outcomes (6)
Breastfeeding rates within 1 hour of age
Mother reported breastfeeding rates within 1 hour of age will be measured following structured survey
6-8 months after the intervention
Breastfeeding rates upto 3 months of age
Mother reported breastfeeding rates after 3 months of age will be measured following structured survey
6-8 months after the intervention
Number of newborns having at least one postnatal check-up within 48 hours.
This measurement will be taken within 2 months of child birth through a structured survey, reported by mother.
6-8 months after the intervention
Number of newborns screened for neonatal jaundice
Number of newborns screened for neonatal jaundice either in home or any government or non-government health facilities within 7 days of birth through a structured survey reported by mother.
6-8 months after the intervention
Number of newborns that received indicated treatment for neonatal jaundice
Number of children receiving indicated treatment for neonatal jaundice either in home or health facilities will be measured by a mother reported structured survey after 2 months of child birth
6-8 months after the intervention
Community health workers (CHW's) skill in assessing sick newborns
CHW's skill will be measured through a structured observation following a check list and subjective and objective assessment by registered physician
During 6-8 months of the intervention
Study Arms (2)
Intervention
ACTIVE COMPARATOREducational session of pregnant mothers, blood grouping of parents and identifying risk factors for developing jaundice, screening newborns for neonatal jaundice, glucose 6-phosphate dehydrogenase deficiency and illness, Home based phototherapy and referral.
Control
NO INTERVENTIONNo intervention will be deliver
Interventions
CHWs will visit the household twice in a month and will counsel mother and families on use of preventive care such as routine antenatal check care and newborn care. The investigators will conduct blood grouping and rhesus (Rh) typing. If the mother is Rh negative, investigators will also measure the Rh status of the father prior to delivery to determine the risk of Rh disease in the newborn. The investigators will establish an emergency contact system both in intervention and comparison arm where mothers and family members contact and inform the research team about delivery. The trained phlebotomist will collect cord blood for measuring glucose 6-phosphate dehydrogenase and infant blood type, Rh status, direct antigen testing. The investigators will develop a protocol for treating infants at home based on the ETAT (Emergency Triage Assessment AND Treatment) AAP (American Academy of Paediatrics) guidelines and treat with LED based phototherapy
Eligibility Criteria
You may qualify if:
- The mothers are at late 2nd or early 3rd trimester of their pregnancy and agreed to enroll as study participants
- They are planning to stay in the study village for the next 12 months (if a mother is planning to give birth at her natal home and then return, she will still not be a candidate for enrollment)
You may not qualify if:
- Pregnant mother with confirmed multiple pregnancy.
- Pregnant mother with medically identified psychological disorder.
- Any known maternal danger sign.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- International Centre for Diarrhoeal Disease Research, Bangladeshlead
- Stanford Universitycollaborator
- Dhaka Shishu Hospitalcollaborator
Study Sites (1)
Mirzapur
Tāngāil, Dhaka Division, Bangladesh
Related Publications (1)
Jahan F, Foote E, Rahman M, Shoab AK, Parvez SM, Nasim MI, Hasan R, El Arifeen S, Billah SM, Sarker S, Hoque MM, Shahidullah M, Islam MS, Ashrafee S, Darmstadt GL. Evaluation of community health worker's performance at home-based newborn assessment supported by mHealth in rural Bangladesh. BMC Pediatr. 2022 Apr 22;22(1):218. doi: 10.1186/s12887-022-03282-6.
PMID: 35459113DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 23, 2019
First Posted
May 1, 2019
Study Start
May 1, 2019
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
March 31, 2022
Record last verified: 2022-03